Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avonex 30microgram inj vials
0802040M0BDAAAE
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pf pens
0802040M0BDACAM
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pfs
0802040M0BDABAF
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Betaferon 300microgram inj vials
0802040M0BCAAAD
|
Betaferon | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Extavia 300microgram inj vials
0802040M0BEAAAD
|
Extavia | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Generic Rebif initiation pack
0802040M0AAALAL
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12 million units/0.5ml inj 1.5ml cart
0802040M0AAAKAK
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12million units/0.5ml inj pf dispos dev
0802040M0AAANAN
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12million units/0.5ml inj pfs
0802040M0AAAGAG
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 30microgram inj vials
0802040M0AAAEAE
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj 1.5ml cartridges
0802040M0AAAJAJ
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj pf dispos dev
0802040M0AAAMAM
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj pfs
0802040M0AAAFAF
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pf dev
0802040M0AAAQAQ
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pfs
0802040M0AAAIAI
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1b 300microgram inj vials
0802040M0AAADAD
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml (6million units) inj pre-filled pens
0802040M0BBAJAM
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj
0802040M0BBALAQ
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj pfs
0802040M0BBAFAI
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22micrograms/0.5ml (6million units) inj 1.5ml cart
0802040M0BBAGAJ
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22micrograms/0.5ml (6million units) inj pfs
0802040M0BBADAF
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj 1.5ml cart
0802040M0BBAHAK
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj pf pens
0802040M0BBAKAN
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj pfs
0802040M0BBAEAG
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 8.8microg/0.1ml with 22microg/0.25ml initiation pack
0802040M0BBAIAL
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.